Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal

Bone Marrow Transplant. 2011 Sep;46(9):1272-3. doi: 10.1038/bmt.2010.285. Epub 2010 Nov 22.

Authors

A Fontanet, Y Chalandon, E Roosnek, B Mohty, J R Passweg

PMID: 21102496
DOI: 10.1038/bmt.2010.285

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Anti-Infective Agents / adverse effects*
Anti-Infective Agents / therapeutic use
Blood Platelets / physiology
Case-Control Studies
Female
Hematologic Diseases / blood
Hematologic Diseases / surgery
Hematopoietic Stem Cell Transplantation*
Humans
Male
Middle Aged
Neutrophils / physiology
Trimethoprim, Sulfamethoxazole Drug Combination / adverse effects*
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
Young Adult

Substances

Anti-Infective Agents
Trimethoprim, Sulfamethoxazole Drug Combination